Serum resistin level among healthy subjects: Relationship to anthropometric and metabolic parameters

Metabolism: Clinical and Experimental

Volumn 54, Issue 4, 2005, Pages 471-475

  Chen, Ching Chu ^a   Li, Tsai Chung ^b   Li, Chia Ing ^a   Liu, Chiu Shong ^a   Wang, Hui Ju ^b   Lin, Cheng Chieh ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY MASS; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MULTIPLE REGRESSION; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 15744365740     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.10.015     Document Type: Article

References (27)

1. C.M. Steppan, S.T. Bailey, and S. Bliat The hormone resistin links obesity to diabetes Nature 409 2001 307 312
2. J.V. Silha, M. Krsek, and J.V. Skrha Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance Eur. J. Endocrinol. 149 2003 331 335
3. J. Junke, S. Engeli, and K. Corzelniak Resistin gene expression in human adipocytes is not related to insulin resistance Obes. Res. 10 2002 1 5
4. K. Azuma, F. Katsukawa, and S. Oguchi Correlation between serum resistin level and adiposity in obese individuals Obes. Res. 11 2003 997 1001
5. M. Degawa-Yamauchi, J.E. Bovenkerk, and B.E. Juliar Serum resistin (FIZZ3) protein is increased in obese humans J. Clin. Endocrinol. Metab. 88 2003 5452 5455
6. J.H. Lee, J.L. Chan, and N. Yiannakouris Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects J. Clin. Endocrinol. Metab. 88 2003 4848 4856
7. K.M. Seow, C.C. Juan, and L.Y. Wu Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance Hum. Reprod. 19 2004 48 53
8. P.G. McTernan, F.M. Fisher, and G. Valsamakis Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes J. Clin. Endocrinol. Metab. 88 2003 6098 6106
9. K.G.M.M. Alberti, P.Z. Zimmet for the WHO Consultation Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation Diabet. Med. 15 1998 539 553
10. D.R. Matthews, J.P. Hosker, and A.S. Rudenski Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in men Diabetologia 28 1985 412 419
11. C.C. Allain, L.S. Poon, and C.S.G. Chan Enzymatic determination of total serum cholesterol Clin. Chem. 20 1974 470 477
12. P. Fossati, and L. Prencipe Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide Clin. Chem. 28 1982 2077 2083
13. P. Roeschlau, E. Bernt, and W. Gruber Enzymatic determination of total cholesterol in serum Z. Klin. Chem. KIin. Biochem. 12 1974 226
14. J.M. Way, C.Z. Gorgun, and Q. Tong Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator- activated receptor gamma agonists J. Biol. Chem. 276 2001 25651 25653
15. D.B. Savage, C.P. Sewter, and E.S. Klenk Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans Diabetes 50 2001 2199 2202
16. J.L. Zhang, Y.W. Qin, and X. Zheng The relationship between human serum resistin level and body fat content, plasma glucose as well as blood pressure Natl. Med. J. China 82 2002 1609 1612
17. H.-C. Fehmann, and J. Heyn Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls Horm. Metab. Res. 34 2002 671 673
18. A. Pfutzner, M. Langenfeld, and T. Kunt Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance Clin. Lab. 49 2003 571 576
19. J. Yang, M. Li, and C.Y. Wu Reduced resistin levels in patients with type 2 diabetes mellitus Natl. Med. J. China 83 2003 1471 1474
20. A. Fujinami, H. Obayashi, and K. Ohta Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes Clin. Chim. Acta 339 2004 57 63
21. M. Yannakoulia, N. Yiannakouris, and S. Bluher Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans J. Clin. Endocrinol. Metab. 88 2003 1730 1736
22. I. Nagaev, and U. Smith Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle Biochem. Biophys. Res. Commun. 285 2001 561 564
23. L. Patel, A.C. Buckels, and I.J. Kinghorn Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators Biochem. Biophys. Res. Commun. 300 2003 472 476
24. K.E. Wellen, and G.S. Hotamisligil Obesity-induced inflammatory changes in adipose tissue J. Clin. Invest. 112 2003 1785 1788
25. H. Xu, G.T. Barnes, and Q. Yang Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J. Clin. Invest. 112 2003 1821 1830
26. M. Jove, A. Planavila, and A. Cabrero Reductions in plasma cholesterol levels after fenofribrate treatment are negatively correlated with resistin expression in human adipose tissue Metabolism 52 2003 351 355
27. S.M. Haffner, L. Mykkanen, and D.L. Rainwater Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men? Obes. Res. 7 1999 164 169